Physician profile
Meghan Louque
NPI 1467846667
$622.99
in general payments reported to CMS, 2019-2025
15 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.04 · 2020: $12.94 · 2021: $34.04 · 2023: $75.15 · 2024: $295 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $139.49 | 2023-2025 | Azstarys |
| Tris Pharma INC | $57.79 | 2019-2024 | Dyanavel Xr |
| Pfizer INC. | $52.13 | 2024 | |
| Neos Therapeutics, LP | $49.41 | 2019-2023 | Cotempla Xr-Odt |
| Glaxosmithkline, LLC. | $49.06 | 2021-2025 | Bexsero, Penmenvy, Rotarix |
| Novo Nordisk INC | $44.85 | 2025 | Wegovy |
| Cranial Technologies, INC | $41.44 | 2024-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $40.83 | 2024 | Qelbree |
| Ironshore Pharmaceuticals INC. | $40.38 | 2019-2023 | Jornay Pm |
| Ironwood Pharmaceuticals, INC | $21.92 | 2024 | |
| Collegium Pharmaceutical, INC. | $20.48 | 2025 | Jornay Pm |
| Sobi, INC | $19.60 | 2023 | |
| Merck Sharp & Dohme LLC | $19.05 | 2021 | |
| Seqirus USA INC | $13.62 | 2024 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Louque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.